From: A systematic review of the effectiveness of policies restricting access to pregabalin
Category: | Search Limits: |
 Databases | PubMed |
 Date range | June 16, 2005–June 15, 2016 |
 Countries | United States |
 Combinations | Pregabalin AND ≥ 1 other relevant term related to restriction policies and health plans) |
Topic: | Search Terms: |
 Drug | Lyrica OR pregabalin |
 Restriction | Restriction |
 Restriction | Prior authorization |
 Restriction | Step edit |
 Restriction | Step therapy |
 Restriction | Prior approval |
 Restriction | Quantity limits |
 Restriction | Fail first requirement |
 Restriction | Step protocol |
 Restriction | Cost sharing |
 Restriction | Cost sharing insurance |
 Health plan | Health plan |
 Health plan | Insurance |
 Health plan | Payer(s) |
 Health plan | Formulary |
 Health plan | Benefit design |
 Other | Access |
 Other | Health care costs |
 Other | Cost effectiveness |
 Other | Health care utilization |
 Other | Health care expenditures |
 Other | Cost analysis |
 Other | Cost utility |
 Other | Cost containment |
 Other | Economics |
 Other | Utilization management |